Drug classes

319 topics, each with its own card and slides.

5-alpha-reductase inhibitors 5-HT3 antagonists (setrons) 5-HT4 prokinetics ACE inhibitors Acid-suppressing drugs ADHD medications (nonstimulants) All (entire library) - alphabetic listing All (entire library) - by Rx rank Allergy drugs Alpha-1 blockers Alpha-2 agonists (central) Aminoglycosides Analgesics Androgen receptor antagonists Anesthetics Angiotensin receptor blockers (ARBs) Angiotensin receptor-neprilysin inhibitor (ARNI) Antacids Anti-amyloid monoclonal antibodies (mAbs) Anti-CD20 antibodies Anti-infectives Antiarrhythmics (Vaughan-Williams IA) Antiarrhythmics (Vaughan-Williams IB) Antiarrhythmics (Vaughan-Williams IC) Antiarrhythmics (Vaughan-Williams III) Antiarrhythmics (Vaughan-Williams IV) Antiarrhythmics (Vaughan-Williams) Antibacterials Antibacterials (cell-wall active) Antibacterials (folate-pathway) Antibacterials (protein-synthesis inhibitors) Antibacterials (sulfonamides) Anticoagulant reversal agents Anticoagulants Anticoagulants (DOACs) Anticoagulants (factor Xa inhibitors) Anticoagulants (heparins & pentasaccharides) Antidepressants Antidepressants (MAOIs) Antidepressants (multimodal serotonergic) Antidepressants (NaSSAs) Antidepressants (NDRIs) Antidepressants (SARIs) Antidepressants (SNRIs) Antidepressants (SSRIs) Antidepressants (TCAs) Antidepressants (tetracyclic) Antidotes Antiemetics Antifungals Antifungals (azoles) Antifungals (polyenes) Antihistamines Antihyperglycemics Antihyperglycemics (DPP-4 inhibitors) Antihyperglycemics (GLP-1 receptor agonists) Antihyperglycemics (meglitinides) Antihyperglycemics (SGLT2 inhibitors) Antihyperglycemics (sulfonylureas) Antihyperglycemics (thiazolidinediones / TZDs) Antihypertensive drugs Antimalarials Antimuscarinics Antimuscarinics (overactive bladder) Antimycobacterials Antineoplastics Antineoplastics (ALK inhibitors) Antineoplastics (alkylating) Antineoplastics (antimetabolites) Antineoplastics (BCR-ABL TKIs) Antineoplastics (BRAF inhibitors) Antineoplastics (BTK inhibitors) Antineoplastics (CDK4/6 inhibitors) Antineoplastics (cytotoxic chemotherapy) Antineoplastics (EGFR inhibitors) Antineoplastics (HDAC inhibitors) Antineoplastics (immune checkpoint inhibitors / ICIs) Antineoplastics (PARP inhibitors) Antineoplastics (topoisomerase I inhibitors) Antiplatelet agents Antiplatelets Antiplatelets (P2Y12 inhibitors) Antipsychotics Antipsychotics (dopamine partial agonists) Antipsychotics (first-generation / FGAs) Antipsychotics (second-generation / SGAs) Antiseizure medications (ASMs) Antiseizure medications (ASMs, succinimides) Antiseizure medications (ASMs, SV2A ligands) Antithrombotics Antitussives Antivirals Antivirals (HBV) Antivirals (HCV NS3/4A protease inhibitors) Antivirals (HCV NS5A inhibitors) Antivirals (herpesvirus) Antivirals (HIV integrase inhibitors) Antivirals (HIV NNRTIs) Antivirals (HIV NRTIs / NtRTIs) Antivirals (HIV protease inhibitors) Antivirals (influenza) Antivirals (SARS-CoV-2) Approved in 2025 Approved in 2026 Aromatase inhibitors Barbiturates Benzodiazepines (BZDs) Beta blockers Beta blockers (alpha/beta) Beta blockers (beta-1 selective) Beta blockers (nonselective) Beta-2 agonists Beta-2 agonists (long-acting / LABAs) Beta-2 agonists (short-acting / SABAs) Beta-3 agonists Bisphosphonates Bone/mineral drugs Boxed warning drugs Bronchodilators Calcineurin inhibitors (topical / TCIs) Calcium channel blockers (CCBs) Calcium channel blockers (CCBs, dihydropyridine) Calcium channel blockers (CCBs, non-dihydropyridine) Cannabinoids Carbapenems Carbonic anhydrase inhibitors (CAIs) Cardiac myosin inhibitors Cardiovascular drugs Cephalosporins Cephalosporins (first-generation) Cephalosporins (second-generation) Cephalosporins (third-generation) CFTR modulators CGRP monoclonal antibodies (mAbs) Chelators Chelators (heavy metals) Chelators (iron) Cholinesterase inhibitors Classical psychedelics COMT inhibitors Controlled substances (all) Controlled substances (Schedule I) Controlled substances (Schedule II) Controlled substances (Schedule III) Controlled substances (Schedule IV) Controlled substances (Schedule V) Corticosteroids Corticosteroids (inhaled / ICS) Corticosteroids (systemic glucocorticoids) Depot formulations Direct vasodilators Discontinued / withdrawn drugs Dissociatives Diuretics Diuretics (loop) Diuretics (osmotic) Diuretics (potassium-sparing) Diuretics (thiazide / thiazide-like) Dopamine agonists Endocannabinoids Endogenous compounds Endogenous neurotransmitters (amino-acid) Endogenous neurotransmitters (monoamine) Endogenous neurotransmitters (opioid peptides) Endothelin receptor antagonists Ergot antimigraine agents Erythropoiesis-stimulating agents (ESAs) Estrogens Extended-release (ER only; no IR marketed) Extended-release (ER preferred over IR) Fluoroquinolones GABA-A neuroactive steroids Gabapentinoids General anesthetics General anesthetics (inhaled) General anesthetics (intravenous) Generic anticipated (2026–2028) Generic available (expensive) Generic unavailable Gepants GI drugs GnRH agonists GnRH antagonists H1 antihistamines H1 antihistamines (first-generation) H1 antihistamines (second-generation) H2 receptor antagonists (H2RAs) Herbals / nutraceuticals Immunomodulators Immunomodulators (fumarates) Immunomodulators (IL-23 pathway biologics) Immunomodulators (IL-4/IL-13 pathway biologics) Immunomodulators (IL-6 pathway biologics) Immunomodulators (JAK inhibitors) Immunomodulators (S1P receptor modulators) Immunomodulators (TNF inhibitors) Immunosuppressants Immunosuppressants (antimetabolites) Immunosuppressants (calcineurin inhibitors / CNIs) Immunosuppressants (mTOR inhibitors) Immunosuppressants / immunomodulators Inhaled formulations Inhaled respiratory drugs Insulins Insulins (long-acting) Insulins (rapid-acting) Intranasal formulations Investigational / not FDA-approved IV-only formulations Laxatives Laxatives (bulk-forming) Laxatives (intestinal secretagogues) Laxatives (osmotic) Laxatives (stimulant) Leukotriene modifiers Lipid-lowering agents Lipid-lowering agents (bile acid sequestrants) Lipid-lowering agents (fibrates) Lipid-lowering agents (omega-3) Lipid-lowering agents (PCSK9 inhibitors) Lipid-lowering agents (statins) Local anesthetics Long-acting injectables (LAIs) Macrolides MAO inhibitors (MAOIs) MAO-B inhibitors Mast-cell stabilizers Metabolites (active) Methylxanthines Mineralocorticoid receptor antagonists (MRAs) Mineralocorticoids Monoaminergic psychotropics Monoclonal antibodies (mAbs) Mood stabilizers Muscarinic antagonists (long-acting / LAMAs) Narrow therapeutic index (NTI) Neurokinin-3 receptor antagonists Neurologic drugs Neuromuscular blockade reversal Neuromuscular blockers Neuromuscular blockers (nondepolarizing) Neuromuscular drugs Nitrates / nitrites (organic) NK1 antagonists NSAIDs Opioid antagonists Opioid antagonists (centrally active) Opioid antagonists (peripheral / PAMORAs) Opioid antidiarrheals Opioids Orexin receptor antagonists Orphan drugs OTC drugs Overdose toxicity (high) Overdose toxicity (relatively low) Oxazolidinones Parent drugs with active metabolites PDE4 inhibitors PDE5 inhibitors Penicillins Pharmacokinetic boosters Phosphate binders Potassium binders Prodrugs Progestins Prostaglandin analogs (ophthalmic) Protein biologics Proton pump inhibitors (PPIs) Psychoactive recreational / experimental compounds Psychotropics PTH receptor agonists Pulmonary vasodilators Pulmonary vasodilators (prostacyclin pathway) RAAS-active drugs REMS medications Respiratory drugs Retinoids Rifamycins Sedative-hypnotics Selective estrogen receptor modulators (SERMs) Sex-hormone drugs Sexual dysfunction (prominent) Skeletal muscle relaxants Soluble guanylate cyclase (sGC) stimulators Somatostatin analogs Steroid hormones / steroid-derived drugs Stimulants Stimulants (amphetamine-class) Stimulants (methylphenidate-class) Stimulants / wake-promoting agents Sublingual / buccal formulations Synthetic analogs of endogenous compounds Targeted antineoplastics Tetracyclines Therapeutic drug monitoring (TDM required) Thionamides Thrombolytics (fibrinolytics) Thyroid hormones Top 100 drugs Top 1000 drugs Top 200 drugs Top 300 drugs Top 400 drugs Top 500 drugs Toxins / toxicants Transdermal formulations Transthyretin (TTR) stabilizers Triptans Urinary antiseptics Vasopressin receptor antagonists (vaptans) Vitamin D and analogs Vitamins and essential cofactors VMAT2 inhibitors Wake-promoting agents (eugeroics) Weight gain (prominent) Weight loss (prominent) Withdrawal (prominent) Xanthine oxidase inhibitors Z-drugs